JSL
REGN icon

JT Stratford LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

JT Stratford LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$599K Sell
775
-33
-4% -$25.3K 0.08% 196
2025
Q4 		$624K Sell
808
-902
-53% -$613K 0.08% 192
2025
Q3 		$961K Sell
1,710
-1,113
-39% -$629K 0.13% 153
2025
Q2 		$1.48M Sell
2,823
-362
-11% -$202K 0.22% 102
2025
Q1 		$2.02M Sell
3,185
-218
-6% -$150K 0.36% 61
2024
Q4 		$2.42M Buy
3,403
+394
+13% +$331K 0.4% 49
2024
Q3 		$3.16M Sell
3,009
-84
-3% -$93.5K 0.54% 35
2024
Q2 		$3.25M Buy
3,093
+1,128
+57% +$1.09M 0.6% 33
2024
Q1 		$1.89M Buy
1,965
+476
+32% +$453K 0.38% 66
2023
Q4 		$1.31M Buy
1,489
+18
+1% +$14.8K 0.3% 87
2023
Q3 		$1.21M Buy
1,471
+382
+35% +$300K 0.31% 87
2023
Q2 		$782K Sell
1,089
-1,157
-52% -$892K 0.21% 117
2023
Q1 		$1.85M Buy
2,246
+261
+13% +$197K 0.53% 47
2022
Q4 		$1.43M Buy
1,985
+1,179
+146% +$870K 0.46% 60
2022
Q3 		$555K Sell
806
-126
-14% -$79.3K 0.2% 101
2022
Q2 		$551K Buy
932
+72
+8% +$46.8K 0.17% 107
2022
Q1 		$601K Sell
860
-268
-24% -$170K 0.18% 103
2021
Q4 		$712K Buy
1,128
+465
+70% +$286K 0.19% 101
2021
Q3 		$401K Buy
+663
New +$412K 0.12% 144

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JT Stratford LLC's REGN Position: Q1 2026 in Review

JT Stratford LLC reduced its Regeneron Pharmaceuticals (REGN) stake by 4.1% in Q1 2026, selling an estimated $25.3K and leaving 775 shares worth $599K. The position accounts for 0.08% of the portfolio, ranked #196.

JT Stratford LLC first reported a position in REGN in Q3 2021 and has held it in 19 quarters since. The position peaked at $3.25M in Q2 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • JT Stratford LLC held 775 shares of Regeneron Pharmaceuticals worth $599K as of Q1 2026.
  • JT Stratford LLC sold 33 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $25.3K.
  • Regeneron Pharmaceuticals made up 0.08% of JT Stratford LLC's portfolio in Q1 2026, its #196 holding.
  • JT Stratford LLC first reported a position in Regeneron Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • JT Stratford LLC's Regeneron Pharmaceuticals position peaked at $3.25M in Q2 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on JT Stratford LLC's 13F filing for Q1 2026, filed 15 May 2026.